March 1, 2026 6:39 am

Category: Life Stories

$420M Partnership Brings New Hope for Better IBD Treatments

A new $420 million partnership between Genentech and OMass Therapeutics is developing innovative oral IBD treatments using groundbreaking protein research technology. This collaboration represents significant hope for better treatment options that could transform daily life for millions living with Crohn’s disease and ulcerative colitis.

You Missed

Surgery Remains a Vital Option for Children with IBD: What Parents Need to Know

Surgery Remains a Vital Option for Children with IBD: What Parents Need to Know

February 22, 2026
Barnacle-Inspired "Living Glue" Shows Promise for Healing IBD Gut Wounds

Barnacle-Inspired “Living Glue” Shows Promise for Healing IBD Gut Wounds

February 21, 2026
Global IBD Cases Surge: What New Research Means for Your Health Journey

Global IBD Cases Surge: What New Research Means for Your Health Journey

February 20, 2026
Sanofi's IBD Drug Shows Promise in Long-Term Extension Study: What This Could Mean for Your Treatment Options

Sanofi’s IBD Drug Shows Promise in Long-Term Extension Study: What This Could Mean for Your Treatment Options

February 19, 2026